Strategic Growth Faber Daeufer & Itrato specializes in corporate and transactional counsel for life sciences and emerging technologies, presenting opportunities to cross-sell services to growing biotech startups and research institutions navigating early-stage financing, IP licensing, and commercial partnerships.
M&A & Partnerships Recent news indicates a significant industry move with Crowell & Moring merging with Faber, signaling enhanced capabilities for deal structuring, due diligence, and collaboration with large firms—a doorway to gray-area partnerships, vendor referrals, and co-counsel engagements on complex transactions.
Operational Scale Revenue in the small-to-mid market range and a lean team suggests a need for scalable contract and R&D transactional support, including template development, repeatable playbooks, and fractional counsel arrangements for growing clients seeking cost-efficient legal services.
Talent & Delivery Ongoing hires in HR and senior attorneys indicate a focus on building expertise and client service capacity; sales conversations can emphasize access to experienced dealmakers, industry-specific knowledge in life sciences, and faster turnaround for complex deals.
Global & Network With more than 800 global clients and a track record across research institutions and investors, there are opportunities to expand network referrals, introduce international collaboration agreements, and offer scalable cross-border deal support to attract multinational startups and SPAC/biotech funding rounds.